Received Jan 29, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | MY9550 | OT / LA |
she got COVID; she got COVID; This is a spontaneous report received from a Consumer or other non HCP. A 77-year-old female patient received BNT162b2 omicron (kp.2) (COMIRNATY (2024-2025 FORMULA)), as dose 1, single (Lot number: MY9550) intramuscular, in left arm for covid-19 immunisation. The patient's relevant medical history included: "allergy to sulfur drugs" (unspecified if ongoing); "allergy to soy" (unspecified if ongoing). Concomitant medication(s) included: ROSUVASTATIN taken for blood cholesterol. Vaccination history included: Covid-19 vaccine (primary series completed, manufacturer unknown), for covid-19 immunization. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "she got COVID". Clinical course: Patient has taken a COVID vaccine every year since the inception of COVID except for 2024 (she got Covid).
Medical History/Concurrent Conditions: Food allergy; Sulfonamide allergy
ROSUVASTATIN